The Claim

In adults with type 2 diabetes and inadequate glycemic control, once-daily IDegLira (insulin degludec/liraglutide combination) reduces postprandial glucose increment by 21.6% over 26 weeks, significantly more than insulin degludec alone (4.1% reduction) and similarly to liraglutide alone (18.4% reduction), as measured by standardized meal test and continuous glucose monitoring.

Source: IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
73score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Quantitative
1 study reviewed
In plain English

In adults with type 2 diabetes who are not controlling their blood sugar well, taking IDegLira once daily for 26 weeks lowers the spike in blood glucose after meals by 21.6%, which is a greater reduction than insulin degludec alone and similar to liraglutide alone.

See the scientific wording

In adults with type 2 diabetes and inadequate glycemic control, once-daily IDegLira (insulin degludec/liraglutide combination) reduces postprandial glucose increment by 21.6% over 26 weeks, significantly more than insulin degludec alone (4.1% reduction) and similarly to liraglutide alone (18.4% reduction), as measured by standardized meal test and continuous glucose monitoring, suggesting the combination enhances glucose control beyond basal insulin therapy.

Why this might work

A drug component activates receptors on the pancreas, causing insulin-producing cells to release more insulin when blood sugar rises after eating, while simultaneously telling sugar-releasing cells to stop releasing sugar. This dual action lowers the spike in blood sugar after meals.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test

    This study shows that taking IDegLira once a day helps people with type 2 diabetes control their blood sugar spikes after meals better than insulin alone, and just as well as the GLP-1 drug alone. It’s like combining two good tools into one better one.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.